Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usefulness of L-carnitine in decompensated liver cirrhosis with carnitine deficiency
jRCT1061200041Recruiting
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levocarnitine in Cirrhosis (2 arms). Primary endpoint: Improvement rate of Child-Pugh score. Started Jan 2021; status: recruiting.
02
Drugs
levocarnitine
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on jRCT1061200041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061200041.